CEL-SCI Corporation

United States · 43 Employees
CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. CEL-SCI's lead investigational therapy, Multikine®* (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent aimed at harnessing the patient's own immune system to produce an anti-tumor response. Data from Phase I and Phase II clinical trials suggest that Multikine simulates the activities of a healthy person's immune system, enabling it to use the body's own anti-tumor immune response. Multikine is the trademark we have registered for this investigational therapy, and this proprietary name is subject to review by the U.S. Food and Drug Administration, or FDA, in connection with our future anticipated regulatory submission for approval.

概述

国家 United States
成立时间 1983
总部 8229 Boone Boulevard, Suite 802, Vienna, Virginia, USA, 22182
电话号码 +1 703-506-9460
网站 http://www.cel-sci.com
LinkedIn http://www.linkedin.com/company/cel-sci-corporation
Twitter http://www.twitter.com/CelSciCorp
Facebook https://facebook.com/celscicorp/
员工数 43
行业 research,
简介 CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. CEL-SCI's lead investigational therapy, Multikine®* (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent aimed at harnessing the patient's own immune system to produce an anti-tumor response. Data from Phase I and Phase II clinical trials suggest that Multikine simulates the activities of a healthy person's immune system, enabling it to use the body's own anti-tumor immune response. Multikine is the trademark we have registered for this investigational therapy, and this proprietary name is subject to review by the U.S. Food and Drug Administration, or FDA, in connection with our future anticipated regulatory submission for approval.

技术

Microsoft Office 365

Other

Outlook

Email Providers

常见问题

CEL-SCI Corporation 在哪里?

CEL-SCI Corporation 的总部位于 8229 Boone Boulevard, Suite 802, Vienna, Virginia, USA, 22182

CEL-SCI Corporation 的电话号码是多少?

CEL-SCI Corporation 的电话号码是 +1 703-506-9460

CEL-SCI Corporation 的官方网站是什么?

CEL-SCI Corporation 的公司官方网站是 http://www.cel-sci.com

CEL-SCI Corporation 是做什么的?

CEL-SCI Corporation 的业务有哪些?

biotechnology,life sciences

CEL-SCI Corporation 的年收入是多少?

CEL-SCI Corporation 的收入是 558000美元

CEL-SCI Corporation 有多少员工?

CEL-SCI Corporation 有 43 名员工

CEL-SCI Corporation 属于哪个行业?

CEL-SCI Corporation 从事以下行业: research

CEL-SCI Corporation 使用什么技术?

CEL-SCI Corporation 使用的一些流行技术包括: Microsoft Office 365,Outlook

如何联系 CEL-SCI Corporation?

CEL-SCI Corporation 联系信息: 电话号码:+1 703-506-9460， 网站:http://www.cel-sci.com， 邮箱：rhu***@***.com

CEL-SCI Corporation 的社交媒体链接是什么?

CEL-SCI Corporation 领英：http://www.linkedin.com/company/cel-sci-corporation,fackbook：https://facebook.com/celscicorp/,twitte:http://www.twitter.com/CelSciCorp

CEL-SCI Corporation 是一家上市公司吗?

是的,CEL-SCI Corporation是一家上市公司,在nasdaq公开挂牌上市，上市交易代码：CVM

CEL-SCI Corporation 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 CEL-SCI Corporation?

CEL-SCI Corporation 有 0 家投资者,包括 。

管理层

Ronald Hunley

Associate Director of Facilities

Tracey Kessler

Director of R&D

Audrey Kues

Director of Quality Assurance

Russell Dillow

Manufacturing Supervisor

Paula Bogier

Lead Environmental Monitoring Technician

员工

Aaron Labrocca

Scientist III

Rebecca McConnell

Assistant Immunologist

Steven Dutton

Facility / Maintenance Administrator

Christopher Madden

General Accountant

Leslie Jones

Research Associate II

外贸获客 查找关键决策人

10亿+海关交易数据，1.2亿企业数据，2亿+企业联系人数据，1000千万真实采购商。覆盖200+个国家及地区，95%外贸重点拓展市场，可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少，成就更大，销售更聪明

查找更多 B2B 联系人，丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google